LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus von Nilsson, Anna C, Janson, Håkan, Wold, Hedda, Fugelli, Anders, Andersson, Karin, Håkangård, Camilla, Olsson, Pernilla, Olsen, Wenche Marie

Volltext

DYRK1a Inhibitor Mediated Rescue of Drosophila Models of Alzheimer’s Disease-Down Syndrome Phenotypes von Zhu, Bangfu, Parsons, Tom, Stensen, Wenche, Mjøen Svendsen, John S., Fugelli, Anders, Hodge, James J. L.

Volltext

In Vitro Activities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Line... von SARAVOLATZ, Louis D, PAWLAK, Joan, JOHNSON, Leonard, BONILLA, Hector, SARAVOLATZ, Louis D, FAKIH, Mohamad G, FUGELLI, Anders, OLSEN, Wenche Marie

Volltext

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome von Stensen, Wenche, Rothweiler, Ulli, Engh, Richard Alan, Stasko, Melissa R., Bederman, Ilya, Costa, Alberto C. S., Fugelli, Anders, Svendsen, John S. Mjøen

Volltext

LTX-109 is a Novel Agent for Nasal Decolonisation of Methicillin Resistant and Sensitive Staphylococcus aureus von Nilsson, Anna, Janson, Håkan, Wold, Hedda, Fugelli, Anders, Andersson, Karin, Håkangård, Camilla, Olsson, Pernilla, Olsen, Wenche Marie

Volltext

DYRK1a inhibitor mediated rescue of Drosophila models of Alzheimer’s disease-Down Syndrome phenotypes von Zhu, Bangfu, Parsons, Tom, Stensen, Wenche, Mjøen Svendsen, John S., Fugelli, Anders, Hodge, James J.L.

Volltext bestellen